相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
Kensuke Toyama et al.
PLOS ONE (2012)
Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels
Ilze Bot et al.
ATHEROSCLEROSIS (2011)
Features of vulnerable plaques and clinical outcome of UA/NSTEMI: Relationship with matrix metalloproteinase functional polymorphisms
Nicola Fiotti et al.
ATHEROSCLEROSIS (2011)
Effects of Exercise Training on the Severity and Composition of Atherosclerotic Plaque in apoE-Deficient Mice
Nikolaos P. E. Kadoglou et al.
JOURNAL OF VASCULAR RESEARCH (2011)
Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes
N. P. E. Kadoglou et al.
DIABETES & METABOLISM (2010)
Voluntary Exercise Ameliorates the Progression of Atherosclerotic Lesion Formation via Anti-Inflammatory Effects in Apolipoprotein E-Deficient Mice
Kosuke Fukao et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Matrix Metalloproteinases in Atherothrombosis
Magnus Back et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2010)
The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment
William Insull
AMERICAN JOURNAL OF MEDICINE (2009)
Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall
Kan Kajimoto et al.
ATHEROSCLEROSIS (2009)
Inflammation and Plaque Vulnerability
Prediman K. Shah
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Risk factor management: antiatherogenic therapies
Stephan Gielen et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2009)
Swimming Prevents Vulnerable Atherosclerotic Plaque Development in Hypertensive 2-Kidney, 1-Clip Mice by Modulating Angiotensin II Type 1 Receptor Expression Independently From Hemodynamic Changes
Maxime Pellegrin et al.
HYPERTENSION (2009)
The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002)
Zory Shaposhnik et al.
JOURNAL OF LIPID RESEARCH (2009)
Molecular Imaging of Matrix Metalloproteinase Expression in Atherosclerotic Plaques of Mice Deficient in Apolipoprotein E or Low-Density-Lipoprotein Receptor
Satoru Ohshima et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Evaluation of Serum Matrix Metalloproteinases as Biomarkers for Detection of Neurological Symptoms in Carotid Artery Disease
Peter Heider et al.
VASCULAR AND ENDOVASCULAR SURGERY (2009)
The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke
Shifang Ding et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2008)
Exercise and carotid atherosclerosis
N. P. E. Kadoglou et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2008)
Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on serum matrix metalloproteinase-13 and tissue inhibitor matrix metalloproteinase-1 levels as a sign of plaque stabilization
Cihan Cevik et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2008)
Molecular Imaging of Matrix Metalloproteinase in Atherosclerotic Lesions
Shinichiro Fujimoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Mouse models for atherosclerosis and pharmaceutical modifiers
Susanne Zadelaar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Other adaptations to training/inactivity in type 2 diabetics and other groups with insulin resistance: emphasis on prevention of CHD
Flemming Dela
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2007)
Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors
Christian K. Roberts et al.
ATHEROSCLEROSIS (2007)
Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: Impact on plaque stabilization?
A Niessner et al.
ATHEROSCLEROSIS (2006)
MMPs - Role in cardiovascular development and disease
PR Brauer
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease
TC Wu et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
The anti-inflammatory effect of exercise
AMW Petersen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Matrix metalloproteinases and diabetic vascular complications
NP Kadoglou et al.
ANGIOLOGY (2005)
Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms
NP Kadoglou et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
MR Law et al.
BRITISH MEDICAL JOURNAL (2003)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Mechanisms of plaque vulnerability and rupture
PK Shah
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats
C Indolfi et al.
CIRCULATION RESEARCH (2002)
Simvastatin promotes atherosclerotic plaque stability in ApoE-deficient mice independently of lipid lowering
F Bea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
YY Li et al.
CARDIOVASCULAR RESEARCH (2000)
分享论文
